Increased Clearance of Morphine in Sickle Cell Disease: Implications for Pain Management
Authors:
- Michael NeelyMNMichael Neely
- John van Den AnkerJAJohn van Den Anker
- Sohail RanaSRSohail Rana
- 1 May 2011
- journal article
- research article
- Published by Elsevier in The Journal of Pain
- Vol. 12 (5) , 531-538
Abstract
No abstract availableKeywords
Funding Information
- National Center for Research Resources (K23AI076106)
- National Institute of Allergy and Infectious Diseases (K23AI076106)
This publication has 44 references indexed in Scilit:
- Morphine tolerance attenuates the resolution of postoperative pain and enhances spinal microglial p38 and extracellular receptor kinase phosphorylationNeuroscience, 2010
- Glomerular Hyperfiltration in Adult Sickle Cell AnemiaClinical Journal of the American Society of Nephrology, 2010
- Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill ChildrenPediatrics, 2010
- Pain site frequency and location in sickle cell disease: The PiSCES projectPain, 2009
- Contribution of Morphine‐6‐Glucuronide to Antinociception following Intravenous Administration of Morphine to Healthy VolunteersThe Journal of Clinical Pharmacology, 2002
- Pharmacokinetics of Opioids in Liver DiseaseClinical Pharmacokinetics, 1999
- Intravenous morphine pharmacokinetics in pediatric patients with sickle cell diseaseThe Journal of Pediatrics, 1995
- Morphine-3-glucuronide - a potent antagonist of morphine analgesiaLife Sciences, 1990
- Book ReviewNeuroanatomy: An atlas of structures, sections and systemsNew England Journal of Medicine, 1987
- Simplified Calculation of Body-Surface AreaNew England Journal of Medicine, 1987